Hepatitis Weekly articles from January 2009

Hepatitis Weekly archives from January 2009

Hepatitis C treatment reduces the virus but liver damage continues.
January 5, 2009... Treating patients who have chronic hepatitis C and advanced liver disease with long-term pegylated interferon significantly decreased their liver enzymes, viral levels and liver inflammation, but the treatment did not slow or prevent the...

New findings reported from Ehime Prefectural Central Hospital describe advances in B-cell lymphoma.
January 5, 2009... According to recent research from Japan, "A primary hepatic marginal zone B cell lymphoma of mucosa-associated lymphoid tissue (MALT) is very rare. We found a solitary mass 27 mm in size in the left lobe of the liver of a 58-year-old Japanese...

Investigators at Mersin University zero in on hepatitis B virus.(Report)
January 5, 2009... Researchers in Mersin, Turkey conducted a study "To investigate the effects of GSTT1, GSTM1 and GSTP1 gene polymorphism on the stage of hepatitis B infection. This study included 116 healthy controls, 56 normal carriers of hepatitis B virus, 69...

Reports outline hepatitis B virus research from B. Muneer and colleagues.
January 5, 2009... According to recent research published in the Southern Medical Journal, "A 58-year-old Arab-American male with HBeAg-negative chronic hepatitis B (HBV), presented with decompensated cirrhosis and a high HBV DNA level. He responded to entecavir...

Research from G.Y. Gwak et al broadens understanding of hepatitis B virus.
January 5, 2009... According to recent research from Seoul, South Korea, "Occult HBV infection that is serum HBsAg negative but HBV-DNA positive is thought to be a contributing factor to ongoing HBV transmission within hemodialysis units. In the present study,...

Researchers at Gaziantep University, Medical Department target hepatitis B virus.
January 5, 2009... "The etiology of most lymphoproliferative disorders remains unclear, though several hypotheses have been proposed. One of the conjectured mechanisms is infection of a tumor clone by an oncologic virus," investigators in Gaziantep, Turkey report...

Scientists at Hiroshima University, Medical Department release new data on hepatitis B virus.(Report)
January 5, 2009... According to a study from Japan, "Although antiviral prophylaxis with the combined high-dose hepatitis B immunoglobulin (HBIg) and lamivudine therapy has effectively reduced post-liver transplantation recurrence of hepatitis B virus infection,...

Findings from T. Pawelczyk and co-authors provide new insights into hepatitis C virus.(Report)
January 5, 2009... According to recent research from Lodz, Poland, "This study was designed to determine the effect of 12-week pegylated IFN alpha plus ribavirin (peg-IFN alpha/RBV) treatment on cognitive performance in chronic hepatitis C (CHC) patients....

Recent findings in hepatitis C virus described by S. Vento and colleagues.
January 5, 2009... "Chronic hepatitis C virus (HCV) infection is a worldwide health problem. Response rates to current standard of treatment (pegylated IFNs and ribavirin) are low in patients with the prevailing genotype 1. To review papers published or...

Reports from University of Alexandria describe recent advances in hepatitis C virus.
January 5, 2009... "Schistsomiasis is a chronic liver disease that is endemic in rural areas of Egypt. Some patients may acquire infection and develop minimal complications while others may develop severe complications and progress to portal hypertension and...

Research by H. Hagan and colleagues in hepatitis C virus provides new insights.(Report)
January 5, 2009... According to recent research published in the American Journal of Epidemiology, "The authors examined the relation between time since onset of illicit drug injection (time at risk) and rates of hepatitis C virus (HCV) infection by using...

Research from M.L. Chang and co-authors provides new data about hepatitis C virus.
January 5, 2009... In this recently published article, scientists in Taipei, Taiwan conducted a study "To identify pre-therapeutic predictors of sustained virological response (SVR) in Taiwanese patients with chronic hepatitis C. One hundred and ninety-eight...

Research from University of Strasbourg provide new insights into hepatitis C virus.
January 5, 2009... "Gene silencing by RNA interference (RNAi) has been shown to represent a recently discovered approach for the treatment of human diseases, including viral infection. A major limitation for the success of therapeutic strategies based on RNAi has...

Scientists at University of Cologne publish research in hepatitis C virus.
January 5, 2009... "Ribavirin has favorable immune-modulating effects in patients with hepatitis C. Therefore, a ribavirin monotherapy preceding the combination of peginterferon plus ribavirin may be beneficial. We conducted a pilot study with a sequential...

Data from Chung-Shan Medical University provide new insights into hepatocellular cancer.(Report)
January 5, 2009... According to recent research from Taichung, Taiwan, "The purpose of this study was to elucidate the protein kinase C (PKC) alpha distribution in human hepatocellular carcinoma (HCC). The histoimmunopathologic technique was used to determine the...

New hepatocellular cancer research from A.K. Singal and co-researchers described.
January 5, 2009... According to a study from the United States, "Prevalence of hepatitis B virus (HBV) related cirrhosis and hepatocellular carcinoma (HCC) is high in Saudi Arabia. However, thee relationship between these two presentations is not well studied."...

Recent findings in hepatocellular cancer described by researchers from St. Louis University.
January 5, 2009... "In patients with chronic hepatitis C who do not have a response to antiviral treatment, the disease may progress to cirrhosis, liver failure, hepatocellular carcinoma, and death. Whether long-term antiviral therapy can prevent progressive...

Scientists at Mansoura University release new data on hepatocellular cancer.(Report)
January 5, 2009... According to recent research from Mansoura, Egypt, "Aflatoxin B1 (AFB1) is an important food-borne mycotoxin. The co-contamination of foodstuffs with this mycotoxin is well known and has been possibly implicated in the development of...

Study data from University of Tokushima provide new insights into hepatocellular cancer.
January 5, 2009... According to a study from Tokushima, Japan, "Spontaneous regression of a malignant tumor, including hepatocellular carcinoma, is extremely, rare. A 78-year-old female with hepatitis B presented with a hepatocellular carcinoma, 3cm in size, in...

Studies from M. Ramoscasal and colleagues provide new data on lupus.
January 5, 2009... "Few studies have evaluated the impact of viral infections on the daily management of patients with systemic lupus erythematosus ISLE). We analyzed the etiology and clinical features of acute viral infections arising in patients with SLE and...

Researchers from RIKEN report recent findings in proteomics.(Report)
January 5, 2009... "The aim of this study was to develop an efficient cell-free protein expression system derived from mammalian cells. We established a HeLa Cell-based in vitro coupled transcription/translation system with T7 RNA polymerase and a plasmid that...

Data from University Hospital, Department of Internal Medicine provide new insights into hepatitis B virus.(Report)
January 5, 2009... New research, 'Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins,' is the subject of a report. "Virus capsids find increasing use as...

New hepatitis B virus epidemiology research from C. Osiowy and colleagues discussed.(Report)
January 5, 2009... Scientists discuss in 'Hepatitis B virus genotype G epidemiology and co-infection with genotype A in Canada' new findings in hepatitis B virus. "Hepatitis B virus (HBV) genotype G (HBV/G) is an unusual variant, and little is known about its...

Reports from University Hamburg add new data to research in hepatitis B virus therapy.
January 5, 2009... Current study results from the report, 'Inhibition of duck hepatitis B virus infection of liver cells by combined treatment with viral e antigen and carbohydrates,' have been published. According to recent research from Hamburg, Germany, "The e...

New hepatitis C virus therapy findings from Schering Plough Research Institute, Department of Virology described.(Report)
January 5, 2009... A report, 'Hepatitis C virus NS5B polymerase exhibits distinct nucleotide requirements for initiation and elongation,' is newly published data in Journal of Biological Chemistry. "The hepatitis C virus (HCV) NS5B protein is an RNA-dependent RNA...

Research from Anhui Medical University reveals new findings on liver fibrosis.(Report)
January 5, 2009... According to a study from Hefei, People's Republic of China, "Bidens bipinnata L. is well known in China as a traditional Chinese medicine and has been used to treat hepatitis in clinics for many years. In a previous study we found that total...

Recent findings in hepatocellular cancer described by researchers from University of Bologna, Department of Microbiology.(Report)
January 5, 2009... Data detailed in 'HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection' have been presented. "Parvovirus B19 has been associated with liver dysfunction and has been considered a potential aetiological agent...

Researchers from Kagawa Medical University report details of new studies and findings in the area of hepatocellular cancer genetics.
January 5, 2009... Investigators publish new data in the report 'Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.' According to a study from Kagawa, Japan, "Annexins (ANXs) constitute a family of Ca2+-dependent...

Dynavax Announces Termination of Partnership With Merck for HEPLISAV[TM] Hepatitis B Vaccine.
January 5, 2009... Dynavax Technologies Corporation (Nasdaq:DVAX) announced the termination of a global license and development collaboration agreement with Merck & Co., Inc. for HEPLISAVTM, a Phase 3 hepatitis B virus (HBV) vaccine. All rights to develop and...

Ener1 to List on the NASDAQ Stock Market.
January 5, 2009... Ener1, Inc. (AMEX:HEV) announced that its Board of Directors has approved the decision to switch the listing of its common stock from the NYSE Alternext U.S. to the NASDAQ Stock Market, effective as of the close of trading on December 31, 2008....

U.S. Li-ion Auto Battery Maker Ener1 Voices Support for $1.6 Billion Federal Grant to Propel Electric Vehicle Technology.
January 5, 2009... A new plan proposed this week by Indiana Senator Evan Bayh involving $1.6 billion in federal grants to accelerate growth of America's advanced hybrid-electric and electric car industry is crucial for American competitiveness in automotive and...

Biostar Pharmaceuticals, Inc. Commences Trading.
January 5, 2009... Biostar Pharmaceuticals, Inc. (BULLETIN BOARD: BSPM) ("Biostar") announced that it has begun trading as a public company under the symbol OTCBB: BSPM (see also Hepatitis). Biostar Pharmaceuticals, Inc., through its wholly-owned subsidiary...

How to tell if a hepatitis-C-virus-infected patient will respond to therapy.
January 5, 2009... Hepatitis C virus (HCV) causes hepatitis and increased risk of developing liver cancer. Current treatments are expensive, have severe side effects, and fail in about half the patients treated. However, the Virahep-C Study Group, at Saint Louis...

New way of viewing cells could lead to easier routes for drug manufacture.
January 5, 2009... Research by a Michigan State University chemist could eventually lead to a quicker and easier way of developing protein-based drugs that are key to treating a number of diseases, including cancer, diabetes and hepatitis (see also Michigan State...

Recent findings in acute hepatitis described by Y.N. Han and colleagues.(Clinical report)
January 12, 2009... According to a study from Shanghai, People's Republic of China, "In areas with high or intermediate endemicity for chronic hepatitis B virus (HBV) infection, it is difficult to distinguish acute hepatitis B (AHB) from chronic hepatitis B with...

Research from L.J. Brant and colleagues has provided new data on acute hepatitis.
January 12, 2009... "The diagnosis of acute hepatitis C virus (HCV) infection is not straightforward; few people exhibit clinical symptoms and genome/antigen detection techniques do not indicate when infection had occurred. Here, a strategy to detect HCV RNA in...

Study data from H.W. Zhang and colleagues update understanding of acute hepatitis.
January 12, 2009... "The major risk factors for acute hepatitis B (AHB) in China and the viral factors determining the progression from acute to chronic hepatitis B remain largely unknown. Epidemiological studies within a population-based surveillance for AHB in...

Findings from G. Imvrios et al in alcoholism reported.
January 12, 2009... "Liver transplantation represents the main treatment for alcoholic cirrhosis. The goal of this article is to review the results of liver transplantation for alcoholic cirrhosis in Greece over the last 2 decades," scientists writing in the...

Report summarizes cirrhosis study findings from L. Gonzalezrapado and co-researchers.
January 12, 2009... "From July 4, 1999, when a liver transplantation program was started in Cuba, to December 30, 2007, we performed 125 procedures in 115 patients. The most frequent reasons for transplantation were cirrhosis caused by hepatitis C virus (29%) and...

Data on hepatitis B virus reported by M. Venegas and co-researchers.
January 12, 2009... "The eight genotypes ( designated A-H) of hepatitis B virus (HBV) display distinctive geographical distribution worldwide, with genotypes A, D and F frequently detected in South America," scientists writing in the journal Archives of Virology...

New hepatitis B virus research has been reported by F.A. Elessawy et al.
January 12, 2009... According to a study from Egypt, "A number of 1,3,4-oxadiazole. 3-9, and 1,2,4-triazole derivatives, 13-15, were synthesized starting form the acid hydrazide 1. The 1,3,4-thiadiazole derivative 12 was prepared from the substituted...

New hepatitis B virus study findings have been reported by F. Fabrizi and co-researchers.
January 12, 2009... "The control of the spread of hepatitis B virus (HBV) infection within dialysis units has been an important goal in the management of patients on regular dialysis but infected patients continue to enter the dialysis system. It is evident that...

Reports from A. Ramezani and co-researchers add new data to research in hepatitis B virus.(Report)
January 12, 2009... "Host genetic and environmental factors are viewed as a common basis of the different outcomes of hepatitis B virus (HBV) infection. Human leukocyte antigen (HLA) plays an important role in immunological reaction to HBV infection,"...

Reports from Xi'an Jiao Tong University, Medical Department add new data to research in hepatitis B virus.
January 12, 2009... According to recent research from Xian, People's Republic of China, "Using a nested-PCR genotyping system, we analyzed the viral genotypes in HBV-infected patients from HBV clustering infection families (CIFs), as compared with HBV infected...

Reports outline hepatitis B virus research from J.M. Pascasio and colleagues.
January 12, 2009... According to recent research from Seville, Spain, "We conducted a retrospective study to evaluate the response to recombinant hepatitis B vaccine after 4 intramuscular doses (40 jig) administered at 0, 1, 2, and 6 months in 157 cirrhotic...

Reports outline hepatitis B virus research from K. Furuta and colleagues.
January 12, 2009... According to a study from Nagoya, Japan, "DNA microarray technology has enabled genomewide analysis of gene transcript levels, yielding insight into the molecular nature of liver disease. We compared gene expression of liver biopsy specimens in...

Research data from Christian Medical College, Medical College update understanding of hepatitis B virus.(Report)
January 12, 2009... "The localization of hepatitis B virus (HBV) core antigen to the nucleus or cytoplasm of hepatocytes has biological implications for viral packaging and persistence. This study examined the relationship between the localization of hepatitis B...

Research data from Yonsei University, Medical Department update understanding of hepatitis B virus.
January 12, 2009... According to recent research published in the Journal of Gastroenterology and Hepatology, "Few studies have assessed the natural history of hepatitis B virus (HBV)-related cirrhotic ascites. We investigated the natural history of patients with...

Research from H.Y. Woo et al has provided new information about hepatitis B virus.
January 12, 2009... "We evaluated the usefulness of dual priming oligonucleotide (DPO)-based multiplex PCR, Seeplex HBV Lami-DR assay (Seegene Institute of Life Sciences, Seoul, Korea), to detect lamivudine-resistant HBV mutants in a comparison with the use of...

Research from S. Laperche and co-researchers provides new data on hepatitis B virus.
January 12, 2009... According to a study from Paris, France, "To take into account the transient nature of hepatitis B virus (HBV) antigenemia, the calculation of HBV residual risk (RR), based on the incidence/window period model, is adjusted by a correction...

Research in the area of hepatitis B virus reported from S. Preiss and colleagues.
January 12, 2009... According to a study from Melbourne, Australia, "Hepatitis B virus (HBV) infection is a major cause of liver-related morbidity and mortality. Toll-like receptors (TLRs) have recently been recognized to play an important role in the pathogenesis...

Research on hepatitis B virus discussed by scientists at University of California.(Report)
January 12, 2009... According to a study from the United States, "Hepatitis B virus (HBV) causes both acute and chronic infection of the human liver and is associated with the development of liver cirrhosis and hepatocellular carcinoma. UBP43 (USP18) is known as...

Study results from Pochon CHA University in the area of hepatitis B virus published.(Report)
January 12, 2009... According to recent research from South Korea, "Collagen type III alpha 1 (COL3A1) is one of the extracelluar matrix (ECM) proteins. The expression of COL3A1 is closely related to chronic liver diseases." "In this study, we investigated...

Study results from University of Milan in the area of hepatitis B virus published.
January 12, 2009... "Nine patients with lamivudine-resistant chronic hepatitis B infection who had been treated with adefovir 10 mg/day and had had a suboptimal response but did not have genotypic resistance to adefovir were treated with high-dose adefovir (20...

Findings from INSERM broaden understanding of hepatitis C virus.(Report)
January 12, 2009... "Entry of the hepatitis C virus (HCV) into the cell seems to be a complex multi-step process involving several cellular factors such as the scavenger class B type I receptor (SRBI)," researchers in Rennes, France report (see also Hepatitis C...

New hepatitis C virus research from A. Manriclue et al outlined.
January 12, 2009... According to a study from Madrid, Spain, "Mycophenolate mofetil (MMF) monotherapy has recently been proposed for liver transplant recipients with adverse events (nephrotoxicity, hypertension) related to calcineurin inhibitors. We analyzed the...

Report summarizes hepatitis C virus study findings from T. Mondal and co-researchers.
January 12, 2009... According to recent research from Bangalore, India, "Human La protein has been implicated in facilitating internal ribosome entry site (IRES)-mediated translation of hepatitis C virus (HCV). Earlier, we demonstrated that the RNA recognition...

Reports from L.T. Aguilar and colleagues advance knowledge in hepatitis C virus.(Report)
January 12, 2009... According to a study from Seville, Spain, "Cirrhosis secondary to hepatitis C virus (HCV) is one of the most frequent indications for liver transplantation. During recent years, the age of donors has increased, which has led to a worse...

Reports outline hepatitis C virus study findings from N. Prabdialsing and colleagues.
January 12, 2009... According to recent research from Johannesburg, South Africa, "Previous studies in South African patients have shown that hepatitis C virus (HCV) prevalence is low (2.6%) and genotype 5 is the dominant genotype. This is the first sequence-based...

Reports outline hepatitis C virus study results from D. Yerly et al.(Report)
January 12, 2009... "Hepatitis C virus (HCV) vaccine efficacy may crucially depend on immunogen length and coverage of viral sequence diversity. However, covering a considerable proportion of the circulating viral sequence variants would likely require long...

Reports summarize hepatitis C virus research from C.M.J. Drapeau and co-authors.
January 12, 2009... "The optimal therapy for HCV-related chronic hepatitis is the combination of pegylated interferon alpha (peg-IFN alpha) plus ribavirin (RBV). Unfortunately, both peg-IFN alpha and RBV are responsible for a wide range of adverse events and...

Research from M. Dutkiewicz and colleagues provide new insights into hepatitis C virus.
January 12, 2009... "Here we present the results of a structural analysis of the 3'-terminal region of the replicative strand of hepatitis C virus (HCV), IRES(-), by the Pb2+-induced cleavage approach and partial digestion with T1 ribonuclease....

Research from University of Pennsylvania in the area of hepatitis C virus described.(Report)
January 12, 2009... "The role of natural killer (NK) cells in controlling hepatitis C virus (HCV) infection and replication has not been fully delineated. We examined NK cell-mediated noncytolytic effect on full cycle HCV infection of human hepatocytes,"...

Research reports from University of Heidelberg provide new insights into hepatitis C virus.
January 12, 2009... According to recent research from Heidelberg, Germany, "Four conserved RNA stem-loop structures designated SL47, SL87, SL248, and SL443 have been predicted in the hepatitis C virus (HCV) core encoding region. Moreover, alternative translation...

Research reports from Wuhan University provide new insights into hepatitis C virus.
January 12, 2009... According to a study from Wuhan, People's Republic of China, "Chronic hepatitis C virus (HCV) infection often leads to liver cancer. The HCV NS2 protein is a hydrophobic transmembrane protein that associates with several cellular proteins in...

Researchers from Case Western Reserve University provide details of new studies and findings in the area of hepatitis C virus.
January 12, 2009... "The activation state, differentiation state, and functions of liver lymphocytes and perihepatic lymph nodes during chronic hepatitis C virus (HCV) infection are not well understood. Here, we performed phenotypic and functional analyses of...

Researchers from Virgen De Las Nieves University publish new studies and findings in the area of hepatitis C virus.
January 12, 2009... According to recent research from Granada, Spain, "Hepatitis C virus (HCV) infection is the main cause of liver disease after renal transplantation. Most patients have seroconverted on dialysis to positive RNA." "The viral load increases...

Studies conducted at University of Essen on hepatitis C virus recently published.
January 12, 2009... "The inherent sequence diversity of the hepatitis C virus (HCV) represents a major hurdle for the adaptive immune system to control viral replication. Mutational escape within targeted CD8 epitopes during acute HCV infection has been well...

Studies from J.A. Perezdaga et al add new findings in the area of hepatitis C virus.(Report)
January 12, 2009... According to a study from Malaga, Spain, "Hepatitis C virus (HCV)-cirrhosis is the most frequent indication for orthotopic liver transplantation (OLT) among adults in most European and American transplant centers. The aim of this study was to...

Study data from M. Wolfl et al provide new insights into hepatitis C virus.
January 12, 2009... "Hepatitis C virus (HCV) infection frequently persists despite eliciting substantial virus-specific immune responses. Thus, HCV infection provides a setting in which to investigate mechanisms of immune escape that allow for viral persistence,"...

Research conducted at E. Dugo and co-authors has provided new information about hepatitis D virus.(Report)
January 12, 2009... According to a study from Rome, Italy, "The objective of this study was to evaluate, by developing one-step real-time PCR, the outcome of superinfection with hepatitis D virus (HDV) genotype I in woodchucks that were chronic carriers of...

Reports outline hepatitis E virus study results from R. Srivastava et al.(Report)
January 12, 2009... According to recent research from Lucknow, India, "The mechanism of liver damage in acute hepatitis E is poorly understood. In this study, we assessed the frequency and activation status of natural killer (NK) and natural killer T (NKT) cells...

Data from J. Briceno and colleagues advance knowledge in hepatocellular cancer.
January 12, 2009... "A better understanding of tumor factors influencing patient and graft survival and recurrence of hepatocellular carcinoma (HCC) associated with hepatitis C virus (HCV) cirrhosis may be useful to maximize the benefits of liver transplantation...

New hepatocellular cancer study results from P.E. Chang et al described.(Report)
January 12, 2009... According to a study from Singapore, Singapore, "Hepatocellular carcinoma (HCC) is uncommon in young adults. This study examined the clinical characteristics and survival outcome of young HCC patients compared with those in older patients." ...

Data from University of Padua advance knowledge in immunization.
January 12, 2009... According to recent research from Padua, Italy, "The prevalence of markers for hepatitis B virus (HBV) and the rate of compliance with HBV vaccination laws were investigated in a study at Padua University Medical School (Italy)." "Of 2,361...

Reports on immunization findings from Sukriti and co-researchers provide new insights.(Report)
January 12, 2009... "The risk of acquiring hepatitis B virus (HBV) infection through exposure to blood or its products is highest amongst health care workers (HCWs). Despite potential risks, a proportion of HCWs never get vaccinated," scientists in New Delhi,...

Research findings from S. Aoufi et al update understanding of immunization.(Report)
January 12, 2009... According to recent research published in the journal Transplantation Proceedings, "Vaccination against hepatitis A virus (HAV) and hepatitis B virus (HBV) is generally recommended for patients with chronic liver disease and those evaluated for...

Research on kidney failure detailed by scientists at Charite University.(Clinical report)
January 12, 2009... According to recent research from Berlin, Germany, "The purpose of this prospective observation cohort study was to develop and validate a risk stratification model for prediction of acute renal failure after liver transplantation." "Data...

Data from J. Carbone et al provide new insights into liver transplant.
January 12, 2009... "J. Carbone, D. Micheloud, M. Salcedo, D. Rincon, R. Banares, G. Clemente, J. Jensen, E. Sarmiento, J. Rodriguez-Molina, E. Fernandez-Cruz. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk...

Data from B. Sanchezperez et al provide new insights into obesity and diabetes.
January 12, 2009... "New-onset posttransplantation diabetes mellitus (PTDM), with an incidence of 10% to 30%, increased graft and patient morbidity and mortality. Such causal factors as age, obesity, therapy, immunosuppression, and hepatitis C virus (HCV)...

Studies from Campinas State University in the area of physiology described.
January 12, 2009... "Sensory neuron diseases (SND) represent a specific subgroup of peripheral nervous system disorders that are becoming increasingly recognized. We aimed to analyze clinical, neurophysiological, and MRI features in patients with SND," scientists...

Reports outline thrombosis research from Johann Wolfgang Goethe University.
January 12, 2009... "Hepatic artery thrombosis after liver transplantation remains a major indication for retransplantation. We report the case of a 49-year-old man with a hepatocellular carcinoma in the setting of cirrhosis associated with chronic hepatitis B and...

Researchers' work from University of Tubingen, Institute for Tropical Medicine focuses on hepatitis B virus.
January 12, 2009... Data detailed in 'Association of two variants of the interferon-alpha receptor-1 gene with the presentation of hepatitis B virus infection' have been presented. According to recent research from Tubingen, Germany, "Interferon-alpha (IFNalpha)...

Reports from University of Bologna, Department of Medicine describe recent advances in hepatitis C virus.
January 12, 2009... New investigation results, 'Alcohol and viral hepatitis: a mini-review,' are detailed in a study published in Digestive and Liver Disease. "Due to their high prevalence in the general population, alcohol use and abuse can be associated with...